Burning Rock Biotech Limited (BNR)

CapEx to Revenue

1.05%

TTM · Retrieved:

BNR logo

BNR CapEx to Revenue

Current (TTM)1.05%
BNR CapEx/Revenue (20.70% → 1.05%)
High-resolution chart · PNG

BNR capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.9728%
1.1587%
1.7461%
11.0133%
42.0287%
18.5016%
11.9824%
11.8329%
20.7024%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.